ustekinumab
janssen
['ustekinumab', 'ibd']
prof s lee: iv reinduction with ustekinumab in cd patients with 2* lor to ust (power) primary endpoint of clinical response not met but some ibdq improvement and maybe a bit of endoscopic improvement #ddw2023 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.